Pregnancy‐associated melanoma epidemiology: A multicentre European studyMaria Kostaki, Alexander J. Stratigos, Ketty Peris et al.|Journal of the European Academy of Dermatology and Venereology|2025Cited by 4
Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter studyEva Ellebæk, Dirk Schadendorf, Michael Weichenthal et al.|EJC Skin Cancer|2025Cited by 1
Pregnancy-associated melanoma epidemiologyMaria Kostaki, Alexander Stratigos, M. Plaka et al.|EJC Skin Cancer|2025Cited by 0
Pregnancy‐associated melanoma: A distinct entity requiring vigilanceMaria Kostaki, Alexander Stratigos, Michaela Plaka et al.|Journal of the European Academy of Dermatology and Venereology|2026Cited by 0
Erratum to “Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study” [EJC Skin Cancer 4 (2026) 100773]Eva Ellebaek, Dirk Schadendorf, Michael Weichenthal et al.|EJC Skin Cancer|2026Cited by 0